다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
Best practice & research. Clinical gastroenterology, v.30 no.1, 2016년, pp.133 - 142
Haque, T.R. , Barritt, A.S.
AI-Helper
The intestinal microbiota have emerged as a topic of intense interest in gastroenterology and hepatology. The liver is on the front line as the first filter of nutrients, toxins and bacterial metabolites from the intestines and we are becoming increasingly aware of interactions among the gut, liver ...
Immunology Marietta 145 3 313 2015 10.1111/imm.12474 Immunogenetic control of the intestinal microbiota
Gut Marchesi 65 2 330 2016 10.1136/gutjnl-2015-309990 The gut microbiota and host health: a new clinical frontier
World J Gastroenterol Tojo 20 41 15163 2014 10.3748/wjg.v20.i41.15163 Intestinal microbiota in health and disease: role of bifidobacteria in gut homeostasis
N Engl J Med Bass 362 12 1071 2010 10.1056/NEJMoa0907893 Rifaximin treatment in hepatic encephalopathy
Hepatology Hou 39 3 746 2004 10.1002/hep.20126 Antibiotic prophylaxis after endoscopic therapy prevents rebleeding in acute variceal hemorrhage: a randomized trial
Ann Pharmacother Segarra-Newnham 44 12 1946 2010 10.1345/aph.1P317 Antibiotic prophylaxis for prevention of spontaneous bacterial peritonitis in patients without gastrointestinal bleeding
Nutr Res Rev Guilloteau 23 2 366 2010 10.1017/S0954422410000247 From the gut to the peripheral tissues: the multiple effects of butyrate
Curr Opin Pharmacol Cani 13 6 935 2013 10.1016/j.coph.2013.09.008 Gut microbiota, enteroendocrine functions and metabolism
Nat Rev Gastroenterol Hepatol Flint 9 10 577 2012 10.1038/nrgastro.2012.156 The role of the gut microbiota in nutrition and health
Liver Int D'Argenio 33 5 687 2013 10.1111/liv.12117 Symbiotic formulation in experimentally induced liver fibrosis in rats: intestinal microbiota as a key point to treat liver damage?
Immunol Cell Biol Maemura 83 4 336 2005 10.1111/j.1440-1711.2005.01323.x Reactive oxygen species are essential mediators in antigen presentation by Kupffer cells
Hepatology Chassaing 59 1 328 2014 10.1002/hep.26494 Microbiota-liver axis in hepatic disease
Nat Med Seki 13 11 1324 2007 10.1038/nm1663 TLR4 enhances TGF-beta signaling and hepatic fibrosis
Nature Turnbaugh 444 7122 1027 2006 10.1038/nature05414 An obesity-associated gut microbiome with increased capacity for energy harvest
Proc Natl Acad Sci U S A Backhed 101 44 15718 2004 10.1073/pnas.0407076101 The gut microbiota as an environmental factor that regulates fat storage
Proc Natl Acad Sci U S A Backhed 104 3 979 2007 10.1073/pnas.0605374104 Mechanisms underlying the resistance to diet-induced obesity in germ-free mice
Nature Ley 444 7122 1022 2006 10.1038/4441022a Microbial ecology: human gut microbes associated with obesity
Proc Natl Acad Sci U S A Zhang 106 7 2365 2009 10.1073/pnas.0812600106 Human gut microbiota in obesity and after gastric bypass
J Pediatr Gastroenterol Nutr Patton 43 4 413 2006 10.1097/01.mpg.0000239995.58388.56 Pediatric nonalcoholic fatty liver disease: a critical appraisal of current data and implications for future research
Am J Epidemiol Lazo 178 1 38 2013 10.1093/aje/kws448 Prevalence of nonalcoholic fatty liver disease in the United States: the Third National Health and Nutrition Examination Survey, 1988-1994
Hepatology Mouzaki 58 1 120 2013 10.1002/hep.26319 Intestinal microbiota in patients with nonalcoholic fatty liver disease
Clin Gastroenterol Hepatol Raman 11 7 868 2013 10.1016/j.cgh.2013.02.015 Fecal microbiome and volatile organic compound metabolome in obese humans with nonalcoholic fatty liver disease
Gut Le Roy 62 12 1787 2013 10.1136/gutjnl-2012-303816 Intestinal microbiota determines development of non-alcoholic fatty liver disease in mice
Hepatology Miele 49 6 1877 2009 10.1002/hep.22848 Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease
PLoS One Ding 5 8 e12191 2010 10.1371/journal.pone.0012191 High-fat diet: bacteria interactions promote intestinal inflammation which precedes and correlates with obesity and insulin resistance in mouse
Cell Mol Gastroenterol Hepatol Llorente 1 3 275 2015 10.1016/j.jcmgh.2015.04.003 The gut microbiota and liver disease
10.1053/j.gastro.2012.01.034 Pendyala S, Walker JM, Holt PR. A high-fat diet is associated with endotoxemia that originates from the gut. Gastroenterology May;142(5):1100-1101 e2.
Can J Gastroenterol French 14 4 327 2000 10.1155/2000/801735 Mechanisms of alcoholic liver injury
Dig Dis Szabo 28 6 737 2010 10.1159/000324281 Gut-liver axis and sensing microbes
FASEB J Rabot 24 12 4948 2010 10.1096/fj.10-164921 Germ-free C57BL/6J mice are resistant to high-fat-diet-induced insulin resistance and have altered cholesterol metabolism
Diabetes Tsukumo 56 8 1986 2007 10.2337/db06-1595 Loss-of-function mutation in Toll-like receptor 4 prevents diet-induced obesity and insulin resistance
J Hepatol Lin 22 2 165 1995 10.1016/0168-8278(95)80424-2 Endotoxemia in patients with chronic liver diseases: relationship to severity of liver diseases, presence of esophageal varices, and hyperdynamic circulation
Hepatology Zhu 57 2 601 2013 10.1002/hep.26093 Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: a connection between endogenous alcohol and NASH
Dig Dis Sci Ferslew 60 11 3318 2015 10.1007/s10620-015-3776-8 Altered bile acid metabolome in patients with nonalcoholic steatohepatitis
J Gastroenterol Hepatol Kirsch 21 1 Pt 1 174 2006 10.1111/j.1440-1746.2005.04220.x Rodent nutritional model of steatohepatitis: effects of endotoxin (lipopolysaccharide) and tumor necrosis factor alpha deficiency
Proc Natl Acad Sci U S A Dumas 103 33 12511 2006 10.1073/pnas.0601056103 Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice
Am J Physiol Gastrointest Liver Physiol Mutlu 302 9 G966 2012 10.1152/ajpgi.00380.2011 Colonic microbiome is altered in alcoholism
Am J Physiol Gastrointest Liver Physiol Bajaj 303 6 G675 2012 10.1152/ajpgi.00152.2012 Colonic mucosal microbiome differs from stool microbiome in cirrhosis and hepatic encephalopathy and is linked to cognition and inflammation
Am J Physiol Gastrointest Liver Physiol Atkinson 280 6 G1280 2001 10.1152/ajpgi.2001.280.6.G1280 Role of protein tyrosine phosphorylation in acetaldehyde-induced disruption of epithelial tight junctions
Am J Physiol Gastrointest Liver Physiol Rao 286 6 G881 2004 10.1152/ajpgi.00006.2004 Recent advances in alcoholic liver disease I. Role of intestinal permeability and endotoxemia in alcoholic liver disease
Alcohol Clin Exp Res Tang 33 7 1220 2009 10.1111/j.1530-0277.2009.00946.x Nitric oxide-mediated intestinal injury is required for alcohol-induced gut leakiness and liver damage
PLoS One Gomez-Hurtado 6 7 e23037 2011 10.1371/journal.pone.0023037 Gut microbiota dysbiosis is associated with inflammation and bacterial translocation in mice with CCl4-induced fibrosis
Eur J Gastroenterol Hepatol Campillo 11 7 755 1999 10.1097/00042737-199907000-00013 Intestinal permeability in liver cirrhosis: relationship with severe septic complications
Aliment Pharmacol Ther Williams 25 Suppl. 1 17 2007 10.1111/j.1746-6342.2006.03217.x Review article: bacterial flora and pathogenesis in hepatic encephalopathy
Lancet Schafer 1 8262 18 1982 10.1016/S0140-6736(82)92559-4 Hepatic encephalopathy and the gamma-aminobutyric-acid neurotransmitter system
Lancet Fischer 2 7715 75 1971 10.1016/S0140-6736(71)92048-4 False neurotransmitters and hepatic failure
Lancet James 2 8146 772 1979 10.1016/S0140-6736(79)92119-6 Hyperammonaemia, plasma aminoacid imbalance, and blood-brain aminoacid transport: a unified theory of portal-systemic encephalopathy
Gut Microbes Rogers 2 1 52 2011 10.4161/gmic.2.1.14761 Distance burning: how gut microbes promote extraintestinal cancers
Gut Fox 59 1 88 2010 10.1136/gut.2009.183749 Gut microbes define liver cancer risk in mice exposed to chemical and viral transgenic hepatocarcinogens
Gut Rocha 54 3 396 2005 10.1136/gut.2004.042168 Association of helicobacter species with hepatitis C cirrhosis with or without hepatocellular carcinoma
Cancer Cell Dapito 21 4 504 2012 10.1016/j.ccr.2012.02.007 Promotion of hepatocellular carcinoma by the intestinal microbiota and TLR4
J Exp Med Broitman 119 633 1964 10.1084/jem.119.4.633 Influence of neomycin and ingested endotoxin in the pathogenesis of choline deficiency cirrhosis in the adult rat
Adv Exp Med Biol Hawkins 368 125 1994 10.1007/978-1-4615-1989-8_13 Neomycin reduces the intestinal production of ammonia from glutamine
Metab Brain Dis Romero-Gomez 24 1 147 2009 10.1007/s11011-008-9124-3 Gut ammonia production and its modulation
Curr Med Res Opin Puxeddu 13 5 274 1995 10.1185/03007999509111552 Rifaximin in the treatment of chronic hepatic encephalopathy
PLoS One Bajaj 8 4 e60042 2013 10.1371/journal.pone.0060042 Modulation of the metabiome by rifaximin in patients with cirrhosis and minimal hepatic encephalopathy
Eur J Gastroenterol Hepatol Gangarapu 27 7 840 2015 10.1097/MEG.0000000000000348 Efficacy of rifaximin on circulating endotoxins and cytokines in patients with nonalcoholic fatty liver disease
Gastroenterology Sharma 137 3 885 2009 10.1053/j.gastro.2009.05.056 Secondary prophylaxis of hepatic encephalopathy: an open-label randomized controlled trial of lactulose versus placebo
Gastroenterology Conn 74 3 624 1978 10.1016/0016-5085(78)90307-4 Lactulose: a drug in search of a modus operandi
Metab Brain Dis Bajaj 27 2 205 2012 10.1007/s11011-012-9303-0 A longitudinal systems biology analysis of lactulose withdrawal in hepatic encephalopathy
Am J Clin Nutr Delzenne 73 2 Suppl. 456S 2001 10.1093/ajcn/73.2.456s Effects of fructans-type prebiotics on lipid metabolism
J Nutr Brighenti 137 11 Suppl. 2552S 2007 Dietary fructans and serum triacylglycerols: a meta-analysis of randomized controlled trials
Eur J Clin Nutr Daubioul 59 5 723 2005 10.1038/sj.ejcn.1602127 Effects of oligofructose on glucose and lipid metabolism in patients with nonalcoholic steatohepatitis: results of a pilot study
J Nutr Biochem Wagnerberger 24 3 531 2013 10.1016/j.jnutbio.2012.01.014 Lactobacillus casei Shirota protects from fructose-induced liver steatosis: a mouse model
Proc Soc Exp Biol Med Nanji 205 3 243 1994 10.3181/00379727-205-43703 Lactobacillus feeding reduces endotoxemia and severity of experimental alcoholic liver (disease)
Obesity (Silver Spring) Cano 21 11 2310 2013 10.1002/oby.20330 Bifidobacterium CECT 7765 improves metabolic and immunological alterations associated with obesity in high-fat diet-fed mice
J Pediatr Gastroenterol Nutr Vajro 52 6 740 2011 10.1097/MPG.0b013e31821f9b85 Effects of Lactobacillus rhamnosus strain GG in pediatric obesity-related liver disease
Eur Rev Med Pharmacol Sci Aller 15 9 1090 2011 Effect of a probiotic on liver aminotransferases in nonalcoholic fatty liver disease patients: a double blind randomized clinical trial
Dig Dis Sci Malaguarnera 57 2 545 2012 10.1007/s10620-011-1887-4 Bifidobacterium longum with fructo-oligosaccharides in patients with non alcoholic steatohepatitis
Alcohol Kirpich 42 8 675 2008 10.1016/j.alcohol.2008.08.006 Probiotics restore bowel flora and improve liver enzymes in human alcohol-induced liver injury: a pilot study
J Hepatol Stadlbauer 48 6 945 2008 10.1016/j.jhep.2008.02.015 Effect of probiotic treatment on deranged neutrophil function and cytokine responses in patients with compensated alcoholic cirrhosis
Eur J Gastroenterol Hepatol Lata 19 12 1111 2007 10.1097/MEG.0b013e3282efa40e The effect of probiotics on gut flora, level of endotoxin and Child-Pugh score in cirrhotic patients: results of a double-blind randomized study
Clin Gastroenterol Hepatol Sawas 13 9 1567 2015 10.1016/j.cgh.2015.05.027 Patients receiving prebiotics and probiotics before liver transplantation develop fewer infections than controls: a Systematic review and meta-analysis
Gastroenterology Vrieze 143 4 913 2012 10.1053/j.gastro.2012.06.031 Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.